FTY720,Sphingosine 1-Phosphate Receptor Modulator,Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibition of T Cell Infiltration

被引:1
|
作者
Hirotoshi Kataoka
Kunio Sugaharal
Kyoko Shimano
Koji Teshima
Mamoru Koyama
Atsyshi Fukunari
Kenji Chiba
机构
[1] Research Laboratory Ⅲ(Immunology) Pharmaceutical Research Unit
[2] Mitsubishi Pharma Corporation
[3] Discovery Technology Laboratory Ⅰ
[4] Yokohama 227-0033.Japan.
[5] Research Laboratory 1(CNS)
[6] Research and Development Division
[7] Yokohama
[8] Aoba-ku
[9] Japan
[10] 1000 Kamoshida-cho
关键词
FTY720; S1P receptor modulator; lymphopenia; EAE; T cell infiltration;
D O I
暂无
中图分类号
R593.2 [自身免疫性疾病、结缔组织疾病];
学科分类号
摘要
FTY720,a sphingosine 1-phosphate receptor modulator,induces a marked decrease in the number of peripheralblood lymphocytes and exerts immunomodulating activity in various experimental allograft and autoimmunedisease models.In this study,we evaluated the effect of FTY720 and its active metabolite,(S)-enantiomer ofFTY720-phosphate [(S)-FTY720-P] on experimental autoimmune encephalomyelitis (EAE) in rats and mice.Prophylactic administration of FTY720 at 0.1 to 1mg/kg almost completely prevented the development of EAE,and therapeutic treatment with FTY720 significantly inhibited the progression of EAE and EAE-associatedhistological change in the spinal cords of LEW rats induced by immunization with myelin basic protein.Consistentwith rat EAE,the development of proteolipid protein-induced EAE in SJL/J mice was almost completely preventedand infiltration of CD4~+ T cells into spinal cord was decreased by prophylactic treatment with FTY720 and(S)-FTY720-P.When FTY720 or (S)-FTY720-P was given after establishment of EAE in SJL/J mice,the relapse ofEAE was markedly inhibited as compared with interferon-β,and the area of demyelination and the infiltration ofCD4~+ T cells were decreased in spinal cords of EAE mice.Similar therapeutic effect by FTY720 was obtained inmyelin oligodendrocyte glycoprotein-induced EAE in C57BL/6 mice.These results indicate that FTY720 exhibitsnot only a prophylactic but also a therapeutic effect on EAE in rats and mice,and that the effect of FTY720 onEAE appears to be due to a reduction of the infiltration of myelin antigen-specific CD4~+ T cells into theinflammation site.Cellular & Molecular Immunology.2005;2(6):439-448.
引用
收藏
页码:439 / 448
页数:10
相关论文
共 50 条
  • [41] The Sphingosine-1-Phosphate Receptor Modulator, FTY720, Reverses Diastolic Dysfunction and Hypertrophy in Hypertrophic Cardiomyopathy
    Ryba, David M.
    Warren, Chad M.
    Karam, Chehade N.
    Dovis, Robert T., III
    Chowdhury, Shamim A. K.
    Alvarez, Manuel G.
    Wieczorek, David F.
    Solaro, R. John
    Wolska, Beata M.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2017, 112 : 156 - 157
  • [42] The mode of action of Fingolimod (FTY720), an oral sphingosine 1-phosphate receptor modulator that is highly effective in human multiple sclerosis (Phase II)
    Brinkmann, V.
    Metzler, B.
    Matloubian, M.
    Mitruecker, H.
    MULTIPLE SCLEROSIS, 2006, 12 : S100 - S100
  • [43] Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice
    Kataoka, H
    Ohtsuki, M
    Shimano, K
    Mochizuki, S
    Oshita, K
    Murata, M
    Sugahara, K
    Sato, N
    Hoshino, Y
    Chiba, K
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 107 - 109
  • [44] FTY720, a sphingosine 1-phosphate receptor modulator, inhibits CD1d-restricted NKT cells by suppressing cytokine production but not migration
    Hwang, Su Jin
    Kim, Ji Hyung
    Kim, Hye Young
    Kim, Sanghee
    Chung, Doo Hyun
    LABORATORY INVESTIGATION, 2010, 90 (01) : 9 - 19
  • [45] MT-1303, a novel sphingosine 1-phosphate (S1P) receptor modulator, ameliorates experimental autoimmune encephalomyelitis (EAE) in mice
    Kataoka, H.
    Shimano, K.
    Maeda, Y.
    Utsumi, H.
    Fukunari, A.
    Sugahara, K.
    Higashi, H.
    Kikuchi, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 686 - 686
  • [46] Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
    Fujino, M
    Funeshima, N
    Kitazawa, Y
    Kimura, H
    Amemiya, H
    Suzuki, S
    Li, XK
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01): : 70 - 77
  • [47] Astrocytic sphingosine 1-phosphate (S1P) receptor subtype 1 signalling influences levels of S1P and cytokines during experimental autoimmune encephalomyelitis and fingolimod (FTY720) intervention
    Choi, J. W.
    Herr, D.
    Kennedy, G.
    Chun, J.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S58 - S58
  • [48] Fingolimod (FTY720) protects synaptic transmission in experimental autoimmune encephalomyelitis
    Rossi, S.
    Cavasinni, F.
    De Chiara, V.
    Musella, A.
    Mataluni, G.
    Cantarella, C.
    Furlan, R.
    Centonze, D.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S178 - S178
  • [49] The sphingosine 1-phosphate receptor agonist FTY720 interfered the distribution of dendritic cell and induced the maternal-fetal immune tolerance
    Xiong, Miao
    Li, Li
    Liu, Yang
    Zhou, Fangfang
    Shi, Nana
    Huang, Hongling
    Wang, Jun
    Zhu, Jieping
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (02) : 1869 - 1877
  • [50] The sphingosine 1-phosphate receptor (S1PR) agonist FTY720 inhibits lymphatic transendothelial migration.
    Lal, Girdhari
    Zhang, Nan
    Ledgerwood, Levi
    Esses, Steven J.
    Bromberg, Jonathan S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 154 - 154